For the Inventor, By the Inventor

Enter assignee name

Bronx, NY, United States of America

Montefiore Medical Center

Calculating rank

USPTO Granted Patents = 65

% Expired Patents = 10.8

CIPO Patents = 2

EPO Patents = 6

Trademarks = 12

Forward Citations = 1,073

Loading Chart...

Loading Chart...

99 inventors (with patents filed for the assignee):

Iraj Lalezari (10 out of 16 patents)

Parviz Lalezari (8 out of 10 patents)

Chandan Guha (6 out of 14 patents)

4. Osamu Matsushita (5 out of 18 patents)

5. Tulasi Ponnapakkam (5 out of 10 patents)

6. Sagaya Theresa Leena Philominathan (5 out of 5 patents)

7. Joshua Sakon (5 out of 16 patents)

8. Ranjitha Katikaneni (5 out of 5 patents)

9. Takaki Koide (5 out of 6 patents)

10. Robert C Gensure (5 out of 11 patents)

11. Richard M LoPachin (4 out of 4 patents)

12. Stephen Barry (4 out of 4 patents)

13. Devdas Shetty (4 out of 5 patents)

14. Avital Fast (4 out of 4 patents)

15. Nozomu Nishi (3 out of 7 patents)

Core Competencies:

Cancer Therapy

Low Energy Immune Priming

Ultrasound Treatment

Drug Delivery

Neutrophil Traps

3D Imaging

Tendinopathy Intervention

Collagen Binding Protein

65 patents: Sort by Forward Citations

1. 12697310 - Multifunctional cytoprotectant for treatment of pathogenic processes mediated by oxidative stress and toxic electrophiles (2026-08-04),

2. 12606630 - CD25 CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF (2026-04-21),

3. 12569454 - Nucleophilic chemicals useful in the treatment of cisplatin-induced sensory neuropathy and ototoxicity (2026-03-10),

4. 12434076 - Low energy immune priming for treating cancer and metastasis (2025-10-07),

5. 12333660 - Methods and devices for intraoperative viewing of patient 3D surface images (2025-06-17),

6. 12260329 - Identifying neutrophil extracellular traps in peripheral blood smears (2025-03-25),

7. 12070628 - Low energy immune priming for treating cancer and metastasis (2024-08-27),

8. 12011619 - Low intensity focused ultrasound for treating cancer and metastasis (2024-06-18),

9. 11992195 - Transfemoral transcaval liver access and devices (2024-05-28),

10. 11727649 - Methods and devices for intraoperative viewing of patient 3D surface images (2023-08-15),

11. 11612716 - Sterilizable fiducial beacon strand for RF target tracking (2023-03-28),

12. 11504100 - Transfemoral transcaval liver access and devices (2022-11-22),

13. 11413255 - Multifunctional cytoprotectant for treatment of pathogenic processes mediated by oxidative stress and toxic electrophiles (2022-08-16),

14. 11279922 - Delivery of therapeutic agents by a collagen binding protein (2022-03-22),

15. 11001820 - Delivery of therapeutic agents by a collagen binding protein (2021-05-11),

Company Overview

Montefiore Medical Center, located in the Bronx, NY, specializes in advanced cancer treatment and innovative therapeutic approaches. The institution focuses on a range of core technologies, including cancer therapy, low energy immune priming, and ultrasound treatment, aimed at enhancing patient outcomes. Additionally, Montefiore is engaged in research related to drug delivery systems, neutrophil traps, and 3D imaging, contributing to the development of novel interventions for conditions such as tendinopathy and leveraging collagen binding proteins for therapeutic applications.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

65 Patents

#3 in Bronx, NY

#338 in New York

#5,619 in US

#11,348 in the World

Bronx, NY, United States of America

Montefiore Medical Center

Forward Citations = 1,073

99 inventors:

Iraj Lalezari (10 out of 16 patents)

Parviz Lalezari (8 out of 10 patents)

Chandan Guha (6 out of 14 patents)

4. Osamu Matsushita (5 out of 18 patents)

5. Tulasi Ponnapakkam (5 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Montefiore Medical Center. Retrieved from https://idiyas.com/company/montefiore-medical-center

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…